25 C
Vientiane
Thursday, November 13, 2025
spot_img

Cision PR Newswire

The 19th China (Chongqing) Senior Citizen Expo concludes successfully

CHONGQING, China, Nov. 13, 2025 /PRNewswire/ -- The 19th China (Chongqing) Senior Citizen Expo and the 1st Western International Conference on High-quality Development of Silver Economy, and the 6th China (Chongqing) Health Industry Expo (hereinafter referred to as the "Senior Citizen Expo") were successfully held at the Chongqing International Expo...

Endogenex™ Appoints Krissy Wright as Chief Financial Officer

Bringing finance, operational, and corporate development expertise to an experienced leadership team. MINNEAPOLIS, Jan. 15, 2025 /PRNewswire/ -- Endogenex, Inc., a clinical-stage medical device company, is...

ZTE, Nokia, and Huawei Lead ABI Research’s 5G FWA CPE Vendor Competitive Ranking

LONDON, Jan. 14, 2025 /PRNewswire/ -- A new Competitive Ranking by global technology intelligence firm ABI Research has found that ZTE is the leading 5G...

Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters

PLANO, Texas, Jan. 14, 2025 /PRNewswire/ -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and...

Korea’s Leading Indie Beauty Brand d’Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- Premium vegan beauty brand d'Alba has achieved significant growth in its overseas sales, rising  to approximately KRW...

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of ‘Pemziviptadil’ for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment,...

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for 'Pemziviptadil...